ICM
ACTG icon

Invenomic Capital Management’s Acacia Research ACTG Stock Holding History

Invenomic Capital Management’s Portfolio ACTG Stock Details ACTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-734,157
Closed -$1.63M – 153
2020
Q1 		$1.63M Buy
+734,157
New +$1.79M 1.33% 22

Other funds holding ACTG

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's ACTG Position: Q2 2020 in Review

Invenomic Capital Management sold out of Acacia Research (ACTG) in Q2 2020, closing a stake of 734,157 shares — an estimated $1.63M sold.

Invenomic Capital Management first reported a position in ACTG in Q1 2020 and held it in 1 quarter. The position peaked at $1.63M in Q1 2020. 84 funds tracked by Wall St. Rank hold ACTG as of Q2 2020.

  • Invenomic Capital Management reported no remaining Acacia Research position as of Q2 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 734,157 Acacia Research shares in Q2 2020, an estimated $1.63M.
  • Invenomic Capital Management first reported a position in Acacia Research in Q1 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Acacia Research position peaked at $1.63M in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Acacia Research as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.